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ABSTRACT
Objective: To analyse the association between
cardiovascular and mental comorbidities of obesity and
weight loss registered in the electronic primary
healthcare records.
Design and setting: Longitudinal study of a cohort
of adult patients assigned to any of the public primary
care centres in Aragon, Spain, during 2010 and 2011.
Participants: Adult obese patients for whom data on
their weight were available for 2010 (n=62 901), and
for both 2010 and 2011 (n=42 428).
Outcomes: Weight loss (yes/no) was calculated based
on the weight difference between the first value
registered in 2010 and the last value registered in
2011. Multivariate logistic regression models were
adjusted for individuals’ age, sex, total number of
chronic comorbidities, type of obesity and length of
time between both weight measurements.
Results: According to the recorded clinical
information, 9 of 10 obese patients showed at least one
chronic comorbidity. After adjusting for covariates,
weight loss seemed to be more likely among obese
patients with a diagnosis of diabetes and/or dementia
and less likely among those with hypertension, anxiety
and/or substance use problems (p<0.05). The
probability of weight loss was also significantly higher
in male patients with more severe obesity and older age.
Conclusions: An increased probability of weight loss
over 1 year was observed in older obese male patients,
especially among those already manifesting high levels
of obesity and severe comorbidities such as diabetes
and/or dementia. Yet patients with certain psychological
problems showed lower rates of weight reduction.
Future research should clarify if these differences persist
beyond potential selective weight documentation in
primary care, to better understand the trends in weight
reduction among obese patients and the underlying role
of general practitioners regarding such trends.
BACKGROUND
While the positive association between severe
obesity and premature death is clearly estab-
lished,1 the relationship of the former with
coexisting comorbidities has been studied to
a lesser extent. In a systematic review of mul-
timorbidity indices, only 5 of the 39 studies
included obesity.2 However, a recent review
of multimorbidity patterns found obesity to
be associated with cardiometabolic, mental
health and musculoskeletal disorders.3
Indeed, obesity is an important independent
predictor of disease clustering,4 and has
been previously described as being the
entrance port to multimorbidity.5 As the
body mass index (BMI) increases, so does
the probability of suffering multiple chronic
conditions.6 A study of the interactions
between obesity and other primary care
registered chronic conditions revealed unex-
pected associations beyond those related to
the well-known metabolic syndrome.3
There is certainly a case for studying
obesity from the perspective of its concomi-
tant health problems. A study about obesity
and functional impairment reported that the
Strengths and limitations of this study
▪ Primary care databases offer great potential for
capturing the constellation of comorbidities
affecting people in the community.
▪ Such data are more informative of the real-life
evolution of patients’ health characteristics (such
as their weight) compared to strictly designed
clinical trials, offering broader opportunities to
move towards patient-centred comparative effect-
iveness research.
▪ Nevertheless, the accuracy and completeness of
diagnostic coding in primary care electronic
health records rely on general practitioners’
efforts and capacity that are often limited, espe-
cially regarding body mass index registration.
This could derive in a potential selection bias
which may limit the external validity of the
present study.
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relationship between both phenomena was primarily
due to medical comorbid conditions.7 Moreover, a large
impact of obesity is derived from the psychosocial
burden, a type of comorbidity that may affect adherence
to medical care.8 Nevertheless, the presence of
weight-related comorbidity has been found to positively
influence weight management in primary care.9 10
Despite its acknowledged impact on individuals’
health, the documentation of BMI and obesity is gener-
ally poor in primary care.6 11 Yet primary care registries
are the preferred data source when studying population-
level occurrence of multimorbidity, because large
numbers of diverse patients are included.12
The aim of this study was to describe the association
between cardiovascular and mental comorbidities of
obesity and weight loss registered in electronic primary
healthcare records.
METHODS
Longitudinal study of a population-based prospective
cohort: The study population was conformed by all adult
patients assigned to any of the public primary care
centres in Aragon during 2010 and 2011, for whom data
on their weight and height were available in 2010
(n=185 645; figure 1). With the aim of avoiding poten-
tially erroneous data, we excluded those patients with
weight or height values outside the ranges of 40–150 kg
and 1.48–2 m, respectively.13 The BMI was calculated for
each individual, and subsequently grouped according to
the categories established by the WHO: underweight
(BMI <18.5); normal weight (BMI 18.5–24.9); overweight
(BMI 25–29.9); obesity type I (BMI 30–34.9); obesity type
II (BMI 35–39.9) and obesity type III (BMI ≥40).14 For
the present study, the first two categories, ie, underweight
and normal weight, were collapsed.
Information on individuals’ sex, age, comorbidities
(coded according to the International Classification of
Primary Care (ICPC)),15 weight and height were
extracted from the electronic medical records for 2010.
To facilitate management of diagnostic information, dis-
eases were grouped according to the Expanded
Diagnostic Clusters (EDC) of the ACG system. This
system groups ICPC codes into 260 EDCs based on the
clinical, diagnostic and therapeutic similarities of dis-
eases. The selection of chronic EDCs was based on a
previously validated list containing 114 EDCs.16 From
the list of all prevalent and/or incident chronic EDCs
occurring during 2010, only cardiovascular and mental
health problems were selected because of (1) the high
frequency of most of these comorbidities among the
obese population and (2) their acknowledged impact on
the clinical approach to obesity, according to the
Figure 1 Flow chart for the study population (BMI, body mass index).
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literature and a previous exploratory analysis performed
by the research group (data not shown).
The outcome variable, weight loss (yes/no), was
obtained only for those patients who suffered obesity in
2010 and for whom data on their weight were available
for the following year (n=42 428; figure 1). It was calcu-
lated based on the weight difference between the first
value registered in 2010 and the last value registered in
2011. No specific weight management interventions
were being developed in primary care at the time of the
study. Consequently, the results of this study are framed
in the context of routine general practice.
The statistical analysis was carried out using STATA/IC
V.12. Results were expressed as relative and absolute fre-
quencies, and the association between comorbidity and
the outcome variable was studied by means of a multi-
variate logistic regression model, adjusting for age, sex,
total number of chronic comorbidities, type of obesity
and length of time (in days) between both weight mea-
surements. ORs and 95% CIs were calculated, and statis-
tical significance was set at p<0.05.
RESULTS
More than half of the individuals for whom BMI data
were available in 2010 were women (55%) and 43%
were over 64 years. Women were over-represented
among patients with obesity types II (60%) and III
(71%). With regard to age, patients with overweight or
obesity were mainly over 44 years, and those with normal
weight were mainly under 45 years of age (table 1).
The percentage of patients with five or more chronic
comorbidities became higher with increasing values of
BMI. Nine of 10 obese patients showed at least one
comorbidity. This proportion was still as high as 68%
among those under 45 years of age. Almost two thirds of
obese patients were diagnosed with hypertension (61%),
37% with dyslipidemia and 24% with diabetes (figure 2).
These numbers were even higher among older indivi-
duals (77%, 41% and 29%, respectively), and as high as
57%, 23% and 18% among middle-aged individuals.
Over half of the obese patients (55%) lost weight
between 2010 and 2011, with an average weight loss at
least twice as high among patients with obesity type III
(8 kg), as compared to those with type I (4 kg) and type
II obesity (5 kg; table 2).
Weight loss was more frequently reported among
obese patients with a diagnosis of diabetes (OR=1.14,
p<0.05) and/or dementia (OR=1.31, p<0.05) after
adjusting for sex, age, rest of the comorbidities, type of
obesity and time between weight measurements. Yet, the
likelihood for losing weight seemed to be between 12%
and 3% lower in obese patients with hypertension
(p<0.05). Mental health conditions, such as anxiety
(OR=0.87, p<0.05) and substance abuse (OR=0.83,
p<0.05), were also negatively associated with weight loss.
The probability of weight loss was also significantly
higher in older male patients, with more severe obesity
and longer length of time between both weight measure-
ments, according to BMI data recorded in the electronic
medical records. The total number of chronic comorbid-
ities was no longer significant after adjusting for the rest
of the covariates (table 3).
Regarding patients with diabetes, those who had been
diagnosed with diabetes in 2010 were more likely to reduce
weight compared to those who had been diagnosed before
2010 (63% vs 57%, p<0.05). When stratifying the analysis
by type of obesity, these differences were statistically signifi-
cant for patients with diabetes with obesity types I (61% vs
55%, p<0.05) and II (65% vs 58%, p<0.05; figure 3).
DISCUSSION
In this study, 92% of obese patients attended to in
primary care had associated comorbidity. The probabil-
ity of weight loss among patients with hypertension,
Table 1 Distribution of body mass index in the population according to demographic variables and number of comorbidities
Normal weight (%) Overweight (%) Obesity type I (%) Obesity type II (%) Obesity type III (%)
n 49 902 72 842 44 619 13 738 4544
Sex
Men 32.40 52.61 50.83 40.00 29.01
Women 67.60 47.39 49.17 60.00 70.99
Age group (years)
15–44 48.00 18.07 12.81 15.42 19.54
45–64 27.20 33.47 34.07 37.22 42.56
≥65 24.80 48.47 53.12 47.36 37.90
Number of chronic comorbidities
0 29.61 12.78 7.77 6.92 7.86
1 25.62 19.39 15.27 13.82 12.87
2 17 19.75 19.27 18 16.97
3 11.24 16.84 18.51 17.6 16.64
4 7.13 12.55 14.81 15.4 15.29
≥5 9.39 18.69 24.36 28.24 30.37
Mean (SD) 1.79 (1.87) 2.74 (2.08) 3.19 (2.13) 3.40 (2.20) 3.50 (2.31)
Number of observations=185 645 (patients for whom data on weight and height were available in 2010).
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anxiety and/or substance use problems was 8%, 13%
and 17% lower, respectively, compared to patients not
presenting with such comorbidities. In contrast, obese
patients with dementia and/or diabetes seemed to be
more likely to lose weight from one year to another,
especially if the latter had been diagnosed in the previ-
ous year. In addition, male sex, higher age, more severe
obesity and longer time-length between weight measure-
ments were all independently associated with weight loss
according to the information recorded in the electronic
medical records.
Primary care databases offer great potential for captur-
ing the constellation of morbidities affecting people in
the community.17 Moreover, such data are more inform-
ative of the real-life evolution of patients’ health
characteristics (such as their weight) compared to strictly
designed clinical trials, offering broader opportunities to
move towards patient-centred comparative effectiveness
research.18 Nevertheless, the accuracy and completeness
of diagnostic coding in primary care electronic health
records rely on general practitioners’ (GPs) efforts and
capacity that are often limited, especially regarding BMI
registration.19 We could not address waist circumference,
which is an important complementary parameter to
assess metabolic health, given that it discriminates body
fat from fat-free mass. It was not possible to include drug
Figure 2 Prevalence (%) of cardiovascular and mental chronic comorbidities in patients with normal weight, overweight and
obesity. Hypertension=hypertension with and without complications. Diabetes=diabetes types I and II with and without
complications.
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use data to shed light on the role of certain medications
such as metformin on weight loss. Although the diagnos-
tic information covered all prevalent and incident
chronic conditions during 2010, we did not consider
those new diagnoses occurring during 2011.
Obesity rarely appears as an isolated condition.
However, the burden of multimorbidity in obese
patients varies among studies. In a primary care-based
study of adults over 30 years in the UK, between 69%
and 79% of obese patients showed at least one add-
itional comorbidity, depending on the type of obesity
and sex.6 In our study, the percentage of obese patients
suffering from one or more chronic comorbidities rose
to 92%, probably due to differences in the number of
baseline chronic diseases considered (114 diseases in
our study vs 11 diseases in the UK study). Similar
results were reported in a Canadian study of the
general adult population of Alberta,4 which was based
on a list of 14 baseline chronic conditions. In this
study, a significantly higher mean number of chronic
disease was reported in the obese population (1.9 dis-
eases) compared to the non-obese population (1.0
diseases); these numbers were higher in our study (3.3
diseases and 1.8 diseases, respectively). Two recent
survey-based studies5 20 also showed a significant step-
wise increase in the prevalence of the majority of
chronic conditions, especially of cardiometabolic risk
factors, from the lowest to the highest BMI category,
although crude prevalences were lower than those
obtained in our study. These differences may be related
to the existence, in our study, of the so-called BMI
recording and/or measurement bias in favour of those
obese patients with a greater morbidity burden who see
their GP more often.11 21 Indeed, in a sensitivity ana-
lysis carried out comparing obese patients with and
without BMI documentation (see online supplementary
table S1), we found that the former were much older,
suffered from a higher mean number of chronic
comorbidities and had a higher prevalence for most of
the studied physical conditions.
A loss of weight between both study years was
recorded for only half of the obese patients studied.
This finding could be in accordance with the debate
regarding the inadequate recognition, documentation
Table 2 Weight differences between 2010 and 2011 in obese patients according to type of obesity, age group and main
comorbidities
N
Weight
loss (%)
Weight
gain (%)
No
differences (%)
Average weight
loss (kg)*
Type of obesity
I 30 000 53.36 41.48 5.16 3.50
II 9412 56.57 39.22 4.22 4.81
III 3016 63.00 33.55 3.45 8.34
Age group (years)
15–44 3018 53.48 41.55 4.97 6.92
45–64 13 635 53.00 42.37 4.63 4.58
≥65 25 775 55.83 39.25 4.92 3.70
No comorbidities 1168 54.21 39.02 6.77 5.81
Cardiovascular comorbidity
Acute myocardial infarction 1182 54.74 41.20 4.06 4.15
Cardiac arrhythmia 2275 55.43 39.78 4.79 4.49
Cardiac valve disorders 621 55.39 40.42 4.19 4.41
Cardiovascular disorders, other 1357 55.78 38.76 5.45 4.28
Cerebrovascular disease 1938 57.12 38.96 3.92 4.06
Congestive heart failure 1134 56.26 39.15 4.59 5.03
Diabetes 12 012 57.44 38.37 4.19 4.09
Dyslipidemia 16 915 54.46 40.95 4.59 4.02
Hypertension 30 404 54.59 40.90 4.51 3.99
Ischaemic heart disease 1832 54.69 39.74 5.57 4.13
Mental comorbidity
Anxiety, neuroses 1256 50.80 44.75 4.46 5.34
Attention deficit disorder 17 41.18 52.94 5.88 1.66
Behaviour problems 154 58.44 38.31 3.25 4.46
Dementia, delirium 380 61.58 33.42 5.00 4.60
Depression 5078 54.96 40.82 4.21 4.34
Personality disorders 84 54.76 41.67 3.57 5.23
Schizophrenia, affective psychosis 600 52.83 43.33 3.83 5.21
Substance use 497 50.10 45.07 4.83 4.37
Number of observations=42 428 (patients with obesity in 2010 for whom data on weight were available in 2011).
Hypertension=hypertension with and without complications.
Diabetes=diabetes types I and II with and without complications.
*Calculated exclusively for obese patients who lost weight between 2010 and 2011.
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and management of obesity by GPs.10 GPs have a clear
opportunity to early diagnose and treat this health
problem in most segments of the population, and their
expertise is highly regarded by patients.22 Indeed, there
is evidence indicating that patients receiving adequate
weight reduction advice in primary care are more likely
to reduce weight than those not receiving any
counselling.23
In our study, older male patients with a higher level of
obesity recently diagnosed from diabetes were more fre-
quently reported to reduce weight from one year to
another. In a German study about the management of
obesity in primary care,19 the presence of vascular com-
plications associated with hypertension or diabetes
seemed to slightly increase the likelihood of using
weight reduction interventions. In a similar US study,9 it
was also stated that management of obesity occurred
more frequently among patients with weight-related
comorbidities such as diabetes, lipid disorders, hyperten-
sion or cardiovascular disease. The impact of weight loss
regarding remission of diabetic symptoms in obese
patients has been widely discussed,24 and seemed to be
a determining factor in our setting, especially if the diag-
nosis of diabetes was made in the previous year.
However, that was not the case for the other cardiovascu-
lar comorbidities considered in our analyses. In fact, suf-
fering from hypertension was negatively associated with
reduction of weight, after adjusting for potential con-
founders. This finding requires further investigation. We
hypothesised that the association between obesity and
hypertension might not be as deep-rooted as thought,
neither among physicians nor among patients. GPs may
focus more on the pharmacological treatment of this
risk factor, while patients could have a lower feeling of
ill health compared to those suffering from a well-
defined disease such as diabetes. Moreover, in patients
with hypertension, nutrition counselling may be based
on hyposodic rather than hypocaloric diets.
Dementia is a well-recognised source of weight loss.
This may in part be explained by reduced food intake
because of impaired autonomy, eating disturbances and
reduced appetite.25 In addition, neurodegenerative pro-
cesses during the presymptomatic stage of the disease
may be responsible for involuntary weight loss.26
Table 3 Multivariate logistic regression
OR p Value 95% CI
Sex 0.95 0.02 0.92 0.99
Age group (years)
45–64 vs 15–44 0.99 0.75 0.91 1.07
≥65 vs 15–44 1.12 0.01 1.03 1.22
Type of obesity
II vs I 1.16 0.00 1.10 1.21
III vs I 1.54 0.00 1.42 1.66
Time between weight measurements (days) 1.00 0.00 1.00 1.00
Number of chronic comorbidities 0.99 0.45 0.98 1.01
Cardiovascular comorbidity
Acute myocardial infarction 0.97 0.63 0.86 1.09
Cardiac arrhythmia 0.99 0.89 0.91 1.09
Cardiac valve disorders 1.01 0.88 0.86 1.19
Cardiovascular disorders, other 1.03 0.63 0.92 1.15
Cerebrovascular disease 1.08 0.11 0.98 1.19
Congestive heart failure 1.00 0.96 0.89 1.14
Diabetes 1.14 0.00 1.09 1.19
Dyslipidemia 0.98 0.31 0.94 1.02
Hypertension 0.92 0.00 0.88 0.97
Ischaemic heart disease 0.96 0.44 0.87 1.06
Mental comorbidity
Anxiety, neuroses 0.87 0.02 0.77 0.97
Attention deficit disorder 0.58 0.28 0.22 1.54
Behaviour problems 1.16 0.37 0.84 1.60
Dementia, delirium 1.31 0.01 1.06 1.61
Depression 1.01 0.69 0.95 1.08
Personality disorders 1.04 0.88 0.67 1.60
Schizophrenia, affective psychosis 0.91 0.26 0.77 1.07
Substance use 0.83 0.04 0.69 0.99
Outcome variable: weight loss between 2010 and 2011 in obese patients (yes/no).
Number of observations=42 428 (patients with obesity in 2010 for whom data on weight were available in 2011).
Maximum likelihood test p<0.001.
Hypertension=hypertension with and without complications.
Diabetes=diabetes types I and II with and without complications.
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Involuntary weight loss is also associated with cholin-
esterase inhibitors in dementia.27 There is evidence for
a higher risk for mental disorders, such as anxiety, in
obese individuals.28 Comorbid anxiety has also been
shown to negatively influence the course of weight in
treated and untreated patients.29 Moreover, substance
use (ie, drug and alcohol) problems may be associated
with the development of other detrimental lifestyles,
such as an unhealthy diet and lack of physical activity,
which may increase the risk of obesity, especially during
youth.30 This could also be the reason for the poorer
weight reduction outcomes among substance users
observed in our study.
Presenting with multiple comorbid conditions has
been shown to be positively associated with receiving
advice to lose weight,31–33 although only about half of
these patients actually received such advice from their
physician.34 In our study, when considering cardiovascu-
lar and mental comorbidities of obesity, the total
number of comorbidities itself was no longer signifi-
cantly associated with weight loss. This was probably
because we had already included a wide range of
chronic conditions in the regression model, neutralising
the explanatory power of the synthetic variable, that is,
number of total comorbidities.
According to Bramlage et al,19 younger overweight
and/or obese patients up to grade I were recognised
and diagnosed considerably less frequently than older
patients and/or those with more severe obesity, which
may explain the lower weight loss rates documented for
these population groups in this study. The association of
older age with greater weight loss may be related to
muscle loss rather than fat loss, especially in the very
elderly. Moreover, the larger weight loss among indivi-
duals with higher grades of obesity could also be
explained by regression to the mean. According to the
study aforementioned, although women had a higher
probability to be diagnosed as overweight or obese than
men, the latter were more likely to use weight reduction
measures,19 which may also elucidate our findings. This
could be explained by women’s role as informal carers
of family members, which may be at the expense of
their own health attitudes.
Perspective
Obesity, which is reaching epidemic proportions glo-
bally,35 increases the risk of suffering from numerous
chronic comorbidities, many of which are life-limiting at
premature ages36 and responsible for the largest part of
the total health costs due to this health problem.37
Therefore, measurement of BMI and clinical recogni-
tion of obesity should be used to identify patients at
high risk of multimorbidity in primary care.
The results of our study describe trends in weight loss
within the community according to information regis-
tered by GPs. For example, we observed an apparently
increased probability of weight loss over 1 year in older
obese male patients, and particularly those already mani-
festing high levels of obesity and severe comorbidities
such as diabetes or dementia. In contrast, patients with
certain psychological problems showed lower rates of
weight reduction. Future research should clarify if these
differences persist beyond potential selective weight
documentation by GPs. Understanding the trends in
weight reduction among obese patients, and the role of
Figure 3 Proportion and 95% CI of obese patients with diabetes who lost weight between 2010 and 2011 according to the year
of diagnosis of diabetes and type of obesity. Number of observations=12 012 (patients with obesity and diabetes in 2010 for
whom data on weight were available in 2011, and who lost weight between both years).
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GPs underlying these trends, could orientate future
primary care strategies.
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